ELUCID
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.
ELUCID
Industry:
Analytics Biotechnology Medical Device
Founded:
2013-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.elucid.com
Total Employee:
51+
Status:
Active
Contact:
617-329-9487
Email Addresses:
[email protected]
Total Funding:
49.73 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud COVID-19 DMARC Shutterstock
Similar Organizations
Enlitic
Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
IAG Capital Partners
IAG Capital Partners investment in Series B - Elucid
Aphelion Capital
Aphelion Capital investment in Series B - Elucid
Bold Brain Ventures
Bold Brain Ventures investment in Series B - Elucid
Biovision Ventures
Biovision Ventures investment in Series B - Elucid
BlueStone Venture Partners
BlueStone Venture Partners investment in Series B - Elucid
MedTex Ventures
MedTex Ventures investment in Series B - Elucid
MedTex Ventures
MedTex Ventures investment in Series A - Elucid
Wolverine Venture Fund
Wolverine Venture Fund investment in Series A - Elucid
IAG Capital Partners
IAG Capital Partners investment in Series A - Elucid
Global Health Impact Fund
Global Health Impact Fund investment in Series A - Elucid
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-26 | Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer |
Official Site Inspections
http://www.elucid.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.82 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elucid"
Elucid - Crunchbase Company Profile & Funding
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first …See details»
Elucid Company Profile 2024: Valuation, Funding & Investors
Elucid General Information Description. Developer of an imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vascular diagnostic …See details»
Elucid Names Kelly Huang as CEO
Jul 22, 2024 Elucid’s PlaqueIQ is the only FDA-cleared computed tomography angiography (CTA) algorithm that objectively quantifies and characterizes plaque validated against ground …See details»
Elucid Company Profile - Office Locations, Competitors, Revenue
Elucid has 5 employees at their 1 location and $47 m in total funding,. See insights on Elucid including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Elucid Names Kelly Huang as CEO - Yahoo Finance
BOSTON, July 22, 2024--Elucid names Kelly Huang, PhD, as president and CEO as part of preparations for commercialization of its flagship plaque analysis software, PlaqueIQ.See details»
Elucid Moves into New Headquarters in Preparation for …
BOSTON, June 27, 2024 — Elucid, a pioneering medical technology company providing physicians with imaging analysis software based on ground truth histology to support …See details»
Elucid - Overview, News & Similar companies | ZoomInfo.com
Jul 1, 2024 Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment …See details»
Elucid - MGMT Boston
Elucid offers software to aid in “cardiovascular disease diagnosis and prevention.” Founded in 2013 (commercially) ... Elucid is in an exciting transitional phase from being an engineering led research organization to a more well rounded scaled …See details»
Elucid mHealth - Crunchbase Company Profile & Funding
Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies. Elucid's novel product, Pill …See details»
Home - Elucid
Elucid's study provided us with essential information on living conditions and healthcare in these remote areas of southern Madagascar. By engaging with the miners and taking on board their needs and proposals for structuring them, …See details»
Elucid Labs - Crunchbase Company Profile & Funding
Elucid Labs is a MedTech company developing augmented intelligence imaging solution for early detection and diagnosis of skin cancer. Its proprietary imaging technology probes the …See details»
Andrew Miller Joins Elucid as Chief Technology Officer
BOSTON, March 28, 2023 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has …See details»
Solution - Elucid
Elucid’s solution for fair and sustainable value chains revolves around three key services: Health Programs, Financial Services, and Impact Reporting. Our health programs. Using digital …See details»
Elucid Social - Crunchbase Company Profile & Funding
Elucid Social integrates businesses with the social good movement through a data-driven strategy that yields measurable results. Elucid Social develops and deploys technologies to assess, …See details»
Elucid Appoints Dr. Michael Lesh to Board of Directors
BOSTON, November 3, 2022 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, …See details»
eLucid Software Reviews, Demo & Pricing - 2024
ELucid is a cloud-based learning management solution designed for industries including banking, information technology and pharmaceuticals. ... The product team needs to think of the …See details»
Elucid Health
At Elucid Health, we are driven by a singular vision: to revolutionize healthcare delivery through innovative technology and data-driven solutions. Since our inception in January 2021, we have …See details»
News - Elucid
Oct 1, 2024 Elucid, Inc., a medical technology company providing physicians AI-powered imaging analysis software to characterize cardiovascular disease, has announced that the …See details»
Elucid Raises $27 Million Series B Funding Round to …
Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing …See details»